Article
Combined pharmacogenetic effect of ADCY9 and ADRB2 gene polymorphisms on the bronchodilator response to inhaled combination therapy
24 Aug 2010
Abstract excerpt
WHAT IS KNOWN AND OBJECTIVE: Inhaled combination therapy composing of long-acting β2-agonist and corticosteroid has been widely applied in the management of asthma, but observed treatment responses vary. The aim of this study was to evaluate the pharmacogenetic effect of the adenylyl cyclase type 9 (ADCY9) gene polymorphism on combination therapy. MATERIALS AND METHODS: Eighty-six mild to moderate Korean...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
